{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:17:01Z","timestamp":1790054221286,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["MSN228402"],"award-info":[{"award-number":["MSN228402"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16SDG27570006"],"award-info":[{"award-number":["16SDG27570006"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005302","name":"University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008959","name":"College of Engineering, University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008959","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK062777"],"award-info":[{"award-number":["R01DK062777"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK095842"],"award-info":[{"award-number":["R01DK095842"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jbc.2023.104946","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T20:22:23Z","timestamp":1687292543000},"page":"104946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Transgenic mice lacking FGF15\/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5130-4413","authenticated-orcid":false,"given":"Young-Chae","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunmi","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0556-8212","authenticated-orcid":false,"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongsook Kim","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.104946_bib1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2023.104946_bib2","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.104946_bib3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-020-14384-z","article-title":"Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase","volume":"11","author":"Byun","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.104946_bib4","article-title":"The role of lipophagy in the development and treatment of non-alcoholic fatty liver disease","volume":"11","author":"Grefhorst","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jbc.2023.104946_bib5","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jbc.2023.104946_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2023.104946_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.livres.2017.11.005","article-title":"Gut microbiota, fatty liver disease, and hepatocellular carcinoma","volume":"2","author":"Chu","year":"2018","journal-title":"Liver Res."},{"key":"10.1016\/j.jbc.2023.104946_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000371670","article-title":"Bile acids as hormones: the FXR-FGF15\/19 pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.jbc.2023.104946_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s42255-019-0074-3","article-title":"Metabolic messengers: fibroblast growth factor 15\/19","volume":"1","author":"Gadaleta","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jbc.2023.104946_bib10","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1038\/s41467-020-19803-9","article-title":"Intestinal FGF15\/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.104946_bib11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1053\/j.gastro.2018.11.061","article-title":"Small heterodimer partner and fibroblast growth factor 19 inhibit expression of NPC1L1 in mouse intestine and cholesterol absorption","volume":"156","author":"Kim","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbc.2023.104946_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13059-015-0835-6","article-title":"Liver ChIP-seq analysis in FGF19-treated mice reveals SHP as a global transcriptional partner of SREBP-2","volume":"16","author":"Kim","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.jbc.2023.104946_bib13","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109997","article-title":"Feeding activates FGF15-SHP-TFEB-mediated lipophagy in the gut","volume":"41","author":"Seok","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2023.104946_bib14","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1074\/jbc.M105161200","article-title":"Dual mechanism for repression of the monomeric orphan receptor liver receptor homologous protein-1 (LRH-1) by the orphan small heterodimer partner (SHP)","volume":"277","author":"Lee","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104946_bib15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41467-018-03060-y","article-title":"AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle","volume":"9","author":"Kim","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.104946_bib16","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ni.2064","article-title":"The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors","volume":"12","author":"Yuk","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2023.104946_bib17","doi-asserted-by":"crossref","first-page":"8656","DOI":"10.1074\/jbc.RA117.001653","article-title":"Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"293","author":"Zou","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104946_bib18","article-title":"Critical role of RanBP2-mediated SUMOylation of small heterodimer partner in maintaining bile acid homeostasis","volume":"7","author":"Kim","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.104946_bib19","doi-asserted-by":"crossref","first-page":"23252","DOI":"10.1074\/jbc.M113.452037","article-title":"Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Czeta is critical for epigenomic regulation of liver metabolic genes","volume":"288","author":"Seok","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104946_bib20","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.15252\/embj.201695500","article-title":"A\u00a0postprandial FGF19-SHP-LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy","volume":"36","author":"Byun","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2023.104946_bib21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cmet.2011.09.003","article-title":"Estrogens and obesity: is it all in our heads?","volume":"14","author":"Hart-Unger","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2023.104946_bib22","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1172\/JCI97736","article-title":"Fasting-induced JMJD3 histone demethylase epigenetically activates mitochondrial fatty acid beta-oxidation","volume":"128","author":"Seok","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2023.104946_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MOL.0000000000000084","article-title":"Intestinal lipid absorption and lipoprotein formation","volume":"25","author":"Hussain","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jbc.2023.104946_bib24","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Chavez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbc.2023.104946_bib25","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3390\/cells10112806","article-title":"Bile acid receptors and the gut-liver axis in nonalcoholic fatty liver disease","volume":"10","author":"Xue","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2023.104946_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2023.104946_bib27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI85499","article-title":"Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease","volume":"127","author":"Stein","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2023.104946_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbc.2023.104946_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jbc.2023.104946_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2023.104946_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/oby.2009.167","article-title":"Microbiota and SCFA in lean and overweight healthy subjects","volume":"18","author":"Schwiertz","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jbc.2023.104946_bib32","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.chom.2018.03.011","article-title":"Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids","volume":"23","author":"Martinez-Guryn","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jbc.2023.104946_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9351","article-title":"T\u00a0cell-mediated regulation of the microbiota protects against obesity","volume":"365","author":"Petersen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.104946_bib34","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2337\/dbi17-0007","article-title":"Targeting FXR and FGF19 to treat metabolic diseases-lessons learned from bariatric surgery","volume":"67","author":"Bozadjieva","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2023.104946_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2017.06.023","article-title":"The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis","volume":"330","author":"Schumacher","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jbc.2023.104946_bib36","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1136\/gutjnl-2016-312975","article-title":"Fibroblast growth factor 15\/19 (FGF15\/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration","volume":"66","author":"Alvarez-Sola","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jbc.2023.104946_bib37","doi-asserted-by":"crossref","first-page":"357ra122","DOI":"10.1126\/scitranslmed.aaf4823","article-title":"Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice","volume":"8","author":"Rao","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2023.104946_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2023.104946_bib39","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2023.104946_bib40","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1194\/jlr.M016048","article-title":"Dissociation of diabetes and obesity in mice lacking orphan nuclear receptor small heterodimer partner","volume":"52","author":"Park","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jbc.2023.104946_bib41","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/hep.29199","article-title":"Hepatic FXR\/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2023.104946_bib42","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/hep.29305","article-title":"Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice","volume":"66","author":"Akinrotimi","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2023.104946_bib43","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2023.104946_bib44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cmet.2009.09.009","article-title":"FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states","volume":"10","author":"Kemper","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2023.104946_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.15252\/embj.201489527","article-title":"A\u00a0dysregulated acetyl\/SUMO switch of FXR promotes hepatic inflammation in obesity","volume":"34","author":"Kim","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2023.104946_bib46","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1038\/s41467-018-04697-5","article-title":"Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis","volume":"9","author":"Byun","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.104946_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.729828","article-title":"Post-translational modifications of FXR; implications for cholestasis and obesity-related disorders","volume":"12","author":"Appelman","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jbc.2023.104946_bib48","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1186\/1471-2164-14-788","article-title":"The Gut Microbiotassay: a high-throughput qPCR approach combinable with next generation sequencing to study gut microbial diversity","volume":"14","author":"Hermann-Bank","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jbc.2023.104946_bib49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/hep.27677","article-title":"FXR-induced lysine-specific histone demethylase, LSD1, reduces hepatic bile acid levels and protects the liver against bile acid toxicity","volume":"62","author":"Kim","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2023.104946_bib50","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/hep.30966","article-title":"MicroRNA-210 promotes bile acid-induced cholestatic liver injury by targeting mixed-lineage leukemia-4 methyltransferase in mice","volume":"71","author":"Kim","year":"2019","journal-title":"Hepatology"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823019749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823019749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:33:56Z","timestamp":1758242036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823019749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0021925823019749"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.104946","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transgenic mice lacking FGF15\/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.104946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"104946"}}